REG - Venture Life Group - Board Update

Venture LifeAnnouncement

19/05/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250519:nRSS1360Ja&default-theme=true

RNS Number : 1360J  Venture Life Group PLC  19 May 2025

19(th) May  2025

VENTURE LIFE GROUP PLC

("Venture Life", "VLG" or the "Company")

Board Update

Venture Life (AIM: VLG), a leader in developing, manufacturing and
commercialising products for the self-care market, provides an update
regarding the Board of the Company.

On 4(th) February 2025 the Company announced that due to potential conflict of
interests, Mr Paul McGreevy had notifed the Board of his intention to step
down from the Board at the time of the announcement of the annual results for
the year ended 31(st) December 2024.

Due to recent changes in circumstances at both the Company and Mr McGreevy's
other interests, the potential conflict of interest previously identified no
longer exists.  As a result, Mr McGreevy has informed the Board that he no
longer needs to step down. The Board has acknowledged and accepted this
notification, and Mr McGreevy will now remain on the Board as Chair.
Commensurate with this the Board will therefore not be seeking to appoint a
replacement non-executive director at this time, as Mark Adams will retain the
role of non-executive director and Chair of the Audit Committee.

Jerry Randall, Chief Executive Officer, commented: "I am delighted that Paul
is able to continue to chair the Company. Since joining us Paul has
contributed significantly to the development of the Company and I am sure he
will continue to do so."

For further information, please contact:

 

 Venture Life Group PLC                                    +44 (0) 1344 578004
 Jerry Randall, Chief Executive Officer

 Daniel Wells, Chief Financial Officer

 Cavendish Capital Markets Limited (Nomad and Broker)      +44 (0) 20 7720 0500
 Stephen Keys / George Lawson (Corporate Finance)

 Michael Johnson (Sales)

About Venture Life (www.venture-life.com (http://www.venture-life.com/) )

Venture Life is an international consumer self-care company focused on
commercialising products for the global self-care market. Headquartered in
the UK, the Group's product portfolio includes Balance Activ in the area of
women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel
product ranges for energy and glucose management and hypoglycaemia, the Health
and Her product range supporting the hormonal lifecycle, the UltraDEX and
Dentyl oral care product ranges. The products, which are typically recommended
by pharmacists or healthcare practitioners, are available primarily through
pharmacies and grocery multiples and are sold in over 90 countries worldwide.
In the UK, Ireland and the US these are supplied direct by the company to
retailers, elsewhere they are supplied by the Group's international
distribution partners.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAAPMMTMTJBTMA